Related Experiment Video
Updated: Mar 5, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.5K
Lithium in late-life mania: a systematic review
Pasquale De Fazio1, Raffaele Gaetano1, Mariarita Caroleo1
1Department of Health Sciences, Psychiatric Unit, University Magna Græcia of Catanzaro.
Neuropsychiatric Disease and Treatment
|March 24, 2017
Summary
Lithium remains an effective and well-tolerated treatment for mania in elderly bipolar disorder (BD) patients. Evidence supports its use as a first-line pharmacologic option in older adults, with careful monitoring.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
- Bipolar Disorder Research
Background:
- Mania affects 0.1% to 0.4% of individuals over 65.
- Treating mania in the elderly presents unique clinical challenges.
- The use of lithium, a standard treatment for bipolar disorder (BD), in older populations has been questioned.
Purpose of the Study:
- To conduct a comprehensive literature review on lithium's efficacy and tolerability for mania in elderly BD patients.
- To evaluate current evidence regarding lithium as a pharmacologic treatment for geriatric mania.
Main Methods:
- Systematic review adhering to PRISMA guidelines.
- Searched EMBASE, MEDLINE, Cochrane Library, and PsycINFO databases (1970-August 2016).
- Keywords included age-related terms, lithium, mood stabilizers, bipolar disorder, and mania; 15 studies met inclusion criteria.
Main Results:
- Limited data exist, but suggest lithium is effective for mania in elderly BD patients.
- Lithium demonstrated good tolerability in this population.
- Evidence indicates lithium may be more effective at lower doses, necessitating close plasma concentration monitoring.
Conclusions:
- Lithium should remain a first-line pharmacologic treatment for mania in elderly patients with bipolar disorder.
- Continued research is needed to further elucidate optimal dosing and monitoring strategies for this demographic.
Related Concept Videos
Mania and Antimanic Drugs: Overview
715
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
715
Bipolar Disorder
1.2K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.2K
Psychosis: Goals of Pharmacotherapy
645
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
645
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
293
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
293

